Cytosorbents

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cytosorbents and other ETFs, options, and stocks.

About CTSO

CytoSorbents Corp. engages in critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio includes CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb. 

CEO
Phillip P. Chan
CEOPhillip P. Chan
Employees
129
Employees129
Headquarters
Princeton, New Jersey
HeadquartersPrinceton, New Jersey
Founded
1997
Founded1997
Employees
129
Employees129

CTSO Key Statistics

Market cap
25.29M
Market cap25.29M
Price-Earnings ratio
-1.38
Price-Earnings ratio-1.38
Dividend yield
Dividend yield
Average volume
73.00K
Average volume73.00K
High today
$0.3999
High today$0.3999
Low today
$0.3637
Low today$0.3637
Open price
$0.3815
Open price$0.3815
Volume
66.46K
Volume66.46K
52 Week high
$1.19
52 Week high$1.19
52 Week low
$0.35
52 Week low$0.35

Stock Snapshot

As of today, Cytosorbents(CTSO) shares are valued at $0.40. The company's market cap stands at 25.29M, with a P/E ratio of -1.38.

On 2026-08-14, Cytosorbents(CTSO) stock moved within a range of $0.36 to $0.40. With shares now at $0.40, the stock is trading +10.0% above its intraday low and 0.0% below the session's peak.

Trading volume for Cytosorbents(CTSO) stock has reached 66.46K, versus its average volume of 73K.

The stock's 52-week range extends from a low of $0.35 to a high of $1.19.

The stock's 52-week range extends from a low of $0.35 to a high of $1.19.

CTSO News

TipRanks 3h
CytoSorbents Shareholders Approve Governance Measures and Reverse Split

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...

Nasdaq 1d
Cytosorbents Q2 2026 Earnings Call Transcript

AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX AD...

Cytosorbents Q2 2026 Earnings Call Transcript
Simply Wall St 5d
US$2.88: That's What Analysts Think Cytosorbents Corporation Is Worth After Its Latest Results

Cytosorbents Corporation ( ) came out with its quarterly results last week, and we wanted to see how the business is performing and what industry forecasts thin...

US$2.88: That's What Analysts Think Cytosorbents Corporation Is Worth After Its Latest Results

People also own

Based on the portfolios of people who own CTSO. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.